Biogen Idec, Inc. (Massachusetts) Reports Another Tysabri Brain Disease Case

LOS ANGELES, Oct 29 (Reuters) - Biogen Idec Inc said on Wednesday that it has notified regulators of a new case of a potentially deadly brain disease in a multiple sclerosis patient being treated with Tysabri in the United States.